MedPath

ipratropium bromide and albuterol sulfate

Ipratropium Bromide and Albuterol Sulfate Inhalation Solution

Approved
Approval ID

cb23ee12-3b8a-4776-bcc0-23f0da66edb3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2019

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ipratropium bromide and albuterol sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63187-529
Application NumberANDA202496
Product Classification
M
Marketing Category
C73584
G
Generic Name
ipratropium bromide and albuterol sulfate
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateNovember 1, 2019
FDA Product Classification

INGREDIENTS (4)

ALBUTEROL SULFATEActive
Quantity: 2.5 mg in 3 mL
Code: 021SEF3731
Classification: ACTIM
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
IPRATROPIUM BROMIDEActive
Quantity: 0.5 mg in 3 mL
Code: J697UZ2A9J
Classification: ACTIR
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ipratropium bromide and albuterol sulfate - FDA Drug Approval Details